Viemed Healthcare, Inc.
VMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $224 | $183 | $139 | $117 |
| % Growth | 22.5% | 31.8% | 18.6% | – |
| Cost of Goods Sold | $91 | $70 | $54 | $44 |
| Gross Profit | $133 | $113 | $85 | $73 |
| % Margin | 59.4% | 61.6% | 61% | 62.7% |
| R&D Expenses | $3 | $3 | $3 | $2 |
| G&A Expenses | $112 | $94 | $73 | $60 |
| SG&A Expenses | $112 | $94 | $73 | $60 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $2 | $0 | -$0 |
| Operating Expenses | $115 | $98 | $76 | $62 |
| Operating Income | $18 | $14 | $8 | $12 |
| % Margin | 8% | 7.8% | 5.9% | 9.9% |
| Other Income/Exp. Net | -$2 | $0 | $1 | $1 |
| Pre-Tax Income | $16 | $14 | $9 | $13 |
| Tax Expense | $5 | $4 | $3 | $3 |
| Net Income | $11 | $10 | $6 | $9 |
| % Margin | 5% | 5.6% | 4.5% | 7.8% |
| EPS | 0.29 | 0.27 | 0.15 | 0.23 |
| % Growth | 7.4% | 80% | -34.8% | – |
| EPS Diluted | 0.28 | 0.25 | 0.15 | 0.22 |
| Weighted Avg Shares Out | 39 | 38 | 39 | 39 |
| Weighted Avg Shares Out Dil | 41 | 40 | 40 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $25 | $22 | $16 | $11 |
| EBITDA | $42 | $37 | $25 | $24 |
| % Margin | 18.9% | 20% | 17.9% | 20.6% |